Clinical Trial Update: CAR- PRISM (PRecision Intervention Smoldering Myeloma) [Phase 2]

View source ↗

Summary

Phase 2 trial update for CAR-PRISM, a cellular therapy for multiple myeloma and smoldering multiple myeloma, sponsored by Dana-Farber Cancer Institute; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Smoldering Multiple Myeloma

Drugs mentioned

• CAR-PRISM

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Multiple Myeloma, Smoldering Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING